| Net Cash Provided by (Used in) Operating Activities |
$35,785,000 |
USD |
-267% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Financing Activities |
$223,638,000 |
USD |
18% |
Q1 2025 |
Q1 2025 |
| Net Cash Provided by (Used in) Investing Activities |
$274,795,000 |
USD |
-4.1% |
Q1 2025 |
Q1 2025 |
| Common Stock, Shares Authorized |
500,000,000 |
shares |
0% |
Q4 2025 |
FY 2025 |
| Common Stock, Shares, Issued |
140,218,764 |
shares |
0.61% |
Q4 2025 |
FY 2025 |
| Common Stock, Par or Stated Value Per Share |
0.01 |
USD/shares |
0% |
Q4 2025 |
FY 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect |
$15,372,000 |
USD |
-58% |
Q1 2025 |
Q1 2025 |
| Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
$190,785,000 |
USD |
43% |
Q4 2025 |
FY 2025 |
| Interest Paid, Excluding Capitalized Interest, Operating Activities |
$91,871,000 |
USD |
-21% |
Q1 2025 |
Q1 2025 |
| Deferred Tax Assets, Valuation Allowance |
$54,800,000 |
USD |
-3.2% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Gross |
$54,800,000 |
USD |
-3.2% |
Q4 2025 |
FY 2025 |
| Depreciation |
$6,500,000 |
USD |
-33% |
Q4 2025 |
FY 2025 |
| Deferred Tax Assets, Operating Loss Carryforwards |
$28,300,000 |
USD |
20% |
Q4 2025 |
FY 2025 |
| Unrecognized Tax Benefits |
$0 |
USD |
|
Q4 2025 |
FY 2025 |
| Additional Paid in Capital |
$2,752,884,000 |
USD |
0.47% |
Q4 2025 |
FY 2025 |
| Interest Expense |
$304,990,000 |
USD |
-31% |
Q4 2025 |
FY 2025 |